Irvine, CA, United States of America

Michael V Bergamini

This inventor holds 1 USPTO granted patent. Top assignee: Allergan Pharmaceuticals. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael V Bergamini. Retrieved from https://idiyas.com/inventor/michael-v-bergamini-ogm76zhv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael V Bergamini: Innovator in Eye Treatment

Introduction

Michael V Bergamini is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of ophthalmology through his innovative methods of treating eye conditions. His work focuses on addressing vascularization of the eye, which can result from various medical conditions.

Latest Patents

Michael holds a patent for a method of treating vascularization of the eye with Flurbiprofen. This method involves topically treating the eye with Flurbiprofen or a pharmaceutically acceptable salt thereof. It is particularly aimed at treating conditions arising from traumatic injury, surgery, such as corneal transplant, or the onset of diabetic retinopathy. He has 1 patent to his name.

Career Highlights

Michael is currently employed at Allergan Pharmaceuticals, a leading company in the field of eye care and pharmaceuticals. His role at Allergan allows him to further develop and refine his innovative approaches to eye treatment.

Collaborations

Michael collaborates with Charles A Cooper, who is also involved in the field of ophthalmology. Their partnership enhances the research and development of effective treatments for eye conditions.

Conclusion

Michael V Bergamini's contributions to the treatment of eye vascularization highlight his dedication to improving patient outcomes. His innovative methods and collaboration with industry professionals continue to advance the field of ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…